Nuveen California Select Tax-Free Income Portfolio (NXC) Stock Price

12.86 ▼ -0.02 (-0.16%)
Open: 12.86 Vol: 0 Day's range: 12.86 - 12.86 Aug 15, 14:34 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
NXC Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 12.89▼ 12.89▼ 12.89▼ 12.88▼ 12.87▼
MA10 12.87▼ 12.87▼ 12.87▼ 12.87▼ 12.88▼
MA20 12.86▼ 12.85▲ 12.86▲ 12.84▲ 12.85▲
MA50 12.90▼ 12.93▼ 12.95▼ 12.88▼ 13.17▼
MA100 12.91▼ 12.89▼ 12.88▼ 12.87▼ 13.08▼
MA200 12.84▲ 12.90▼ 12.92▼ 13.04▼ 13.53▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.006▲ 0.006▲ 0.006▲ 0.006▲ 0.019▲
RSI 47.617▼ 47.235▼ 47.201▼ 49.521▼ 47.145▼
STOCH 61.905     61.905     58.356     61.556     38.401    
WILL %R -85.714▼ -42.857     -42.857     -37.500     -62.963    
CCI -21.705     -1.200     -19.023     11.530     13.076    
Latest Filters Detected On NXC
RSI $NXC RSI(14) Crossed Below 50 Set Alert
MA $NXC Price Crossed Below MA(50) Set Alert
MA $NXC Price Crossed Below MA(26) Set Alert
MA $NXC Price Crossed Below MA(13) Set Alert
MA $NXC Price Crossed Below MA(7) Set Alert
CDL $NXC Doji Candlestick Pattern Detected Set Alert
Nuveen California Select Tax-Free Income Portfolio News
Immix Biopharma Announces Other Serious Diseases Strategy
Wednesday, August 06, 2025 09:42 AM
Dosing ongoing and planned in a handful of Other Serious Diseases (OSD) – – Company plans to partner-out Other Serious Disease programs – – On track for first Biologics License Application (BLA) ...
AT&T to dual list on NYSE Texas in latest win for new exchange
Thursday, July 31, 2025 01:36 PM
AT&T will dual list on the NYSE Texas, the U.S. wireless carrier said on Thursday, marking the latest company to be drawn to the Lone Star state's pro-business policies, lower taxes and strong ...
Immix Biopharma Announces Class-Leading Safety Profile, Allowing Potential Future Indication Expansion
Friday, July 11, 2025 01:36 AM
Absence of neurotoxicity of any grade in low-volume disease to-date – – On track for first Biologics License Application (BLA) approved cell therapy in orphan indication r ...
NXC historical stock data
date open high low close volume
15/08/25 12.86 12.86 12.86 12.86 7,979
14/08/25 12.90 12.90 12.85 12.88 6,322
13/08/25 12.90 12.9318 12.8616 12.9318 6,514
12/08/25 12.85 12.91 12.85 12.85 18,965
11/08/25 12.89 12.95 12.8501 12.90 14,412
08/08/25 12.80 12.90 12.80 12.84 22,400
07/08/25 12.82 12.875 12.79 12.86 8,769
06/08/25 12.88 12.88 12.79 12.80 21,400
05/08/25 12.87 12.94 12.87 12.88 24,365
04/08/25 12.85 12.90 12.85 12.86 10,000
Quote Details
52wk Low:12.41
52wk High:14.18
Vol:0
Avg Vol(3m):251.9K
1Y Chng:-6.13%
1M Chng:-0.69%
Add to Watch List
More Information
Index N/A
Market Cap. 82.92M